Patients (n) | Sex | Age (y) | Tumor location | Histology | Tumor stage | SUVmax | Tumor size* (mm) | Tumor volume+(cm3) |
---|---|---|---|---|---|---|---|---|
1 | M | 66 | Upper lobe | Adenocarcinoma | T2N2 | 25.51 | 36 | 17.49 |
2 | F | 68 | Lower lobe | Adenosquamous carcinoma | T2N2 | 11 | 46 | 139.72 |
3 | M | 70 | Upper lobe | Adenocarcinoma | T2N2 | 7.71 | 18 | 4.81 |
4 | M | 79 | Upper lobe | Adenocarcinoma | T1N2 | 8.8 | 33 | 26.40 |
5 | F | 49 | Lower lobe | Squamous cell carcinoma | T2N2 | 8.85 | 38 | 38.59 |
6 | M | 66 | Upper lobe | Squamous cell carcinoma | T2N2 | 14.41 | 33 | 16.28 |
7 | M | 75 | Upper lobe | Squamous cell carcinoma | T2N2 | 12.39 | 32 | 14.37 |
8 | F | 65 | Upper lobe | Adenocarcinoma | T2N2 | 13.41 | 25 | 8.12 |
9 | M | 76 | Lower lobe | Squamous cell carcinoma | T3N2 | 15.13 | 52 | 115.42 |
10 | M | 84 | Lower lobe | Adenocarcinoma | T2N2 | 24.81 | 40 | 27.53 |
11 | M | 68 | Upper lobe | Squamous cell carcinoma | T2N2 | 9.83 | 40 | 45.97 |
12 | M | 65 | Upper lobe | Adenocarcinoma | T2N3 | 14.38 | 42 | 39.43 |
13 | F | 67 | Upper lobe | Adenocarcinoma | T1N3 | 6.99 | 15 | 5.96 |
14 | M | 65 | Upper lobe | Squamous cell carcinoma | T4N2 | 14.52 | 80 | 157.67 |
15 | M | 45 | Upper lobe | Adenocarcinoma | T1N3 | 6.09 | 10 | 5.06 |
16 | M | 65 | Lower lobe | Adenocarcinoma | T1N2 | 6.07 | 24 | 4.53 |
17 | M | 60 | Upper lobe | Squamous cell carcinoma | T4N1 | 11.34 | 34 | 19.95 |